Rivastigmine modestly improves dementia associated with Parkinson's disease, but has important adverse effects

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Rivastigmine modestly improves dementia associated with Parkinson's disease, but has important adverse effects.

Patients: 541 people over the age of 50 years diagnosed with Parkinson’s disease (PD; UK PD Society Brain Bank criteria) and mild to moderate PD related dementia (DSM-IV; Mini Mental State Examination (MMSE) score 10–24). Exclusion criteria were: non-PD neurodegeneration; unstable medical comorbidity, disability, or dementia not related to PD; active, uncontrolled seizures; prior major depressi...

متن کامل

Rivastigmine for dementia associated with Parkinson's disease.

BACKGROUND Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such patients. METHODS Patients in whom mild-to-moderate dementia developed at least 2 years after they received a clinical diagnosis of Parkinson's disease were randomly assigned to receive placebo or...

متن کامل

Rivastigmine for the treatment of dementia associated with Parkinson’s disease

Parkinson's disease (PD) afflicts millions of people worldwide and leads to cognitive impairment or dementia in the majority of patients over time. Parkinson's disease dementia (PDD) is characterized by deficits in attention, executive and visuospatial function, and memory. The clinical diagnostic criteria and neuropathology surrounding PDD remain controversial with evidence of overlap among PD...

متن کامل

Rivastigmine: in Parkinson's disease dementia.

Rivastigmine is a carbamate-type dual inhibitor of brain acetyl- and butyrylcholinesterases that has been evaluated in the symptomatic treatment of patients with mild to moderate dementia associated with idiopathic Parkinson's disease. Oral rivastigmine 3-12 mg/day for 24 weeks was significantly more effective than placebo in ameliorating cognitive and functional decline, including attentional ...

متن کامل

P 84: Daily Nutrition has a Grand but Inapparent Effect on the Procedure of Inflammatory Dementia

Alzheimer is age-related, progressive brain degeneration disease. It destroys memory slowly. The number of people living with AD is increasing as fast as the count of aged population and extension of bad nutrition habits. The main cause of AD is not clearly known, but prior studies noted the importance of inflammation in Tau hyperphosphorylation and failure of microglia to clear AB peptide accu...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Evidence-Based Mental Health

سال: 2005

ISSN: 1362-0347

DOI: 10.1136/ebmh.8.2.41